As of December 31, 2025, Immuron Limited carries a market capitalization of 11.76M, placing it among publicly traded companies globally. Its enterprise value stands at 1.76M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11.76M |
| Enterprise Value | 1.76M |
Immuron Limited's next confirmed earnings release is scheduled for February 19, 2027.
| Earnings Date | 2/19/2027 |
As of December 31, 2025, Immuron Limited has 326.65M shares outstanding.
| Shares Outstanding | 326.65M |
These figures are as of December 31, 2025.
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.90 |
As of December 31, 2025, Immuron Limited maintains a current ratio of 8.04, meaning it holds 8.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 8.04 |
| Quick Ratio | 6.75 |
As of the close on October 22, 2026, Immuron Limited's stock has declined approximately 52.38% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.04.
| 52-Week Price Change | -52.38% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.04 |
These figures are as of December 31, 2025. Total book value stands at 13.08M, with working capital of 13.07M providing operational flexibility.
| Cash & Cash Equivalents | 10.00M |
| Net Debt | -10.00M |
| Equity (Book Value) | 13.08M |
| Book Value Per Share | 0.04 |
| Working Capital | 13.07M |
Immuron Limited's most recent stock split took place on June 2, 2016 with a 335:338 split ratio.
| Last Split Date | 6/2/2016 |
| Split Ratio | 335:338 |
Already premium?